Contact Dermatitis Caused by Efinaconazole and Luliconazole.
contact dermatitis
cross-reaction
efinaconazole
luliconazole
triazole
Journal
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
ISSN: 1347-3409
Titre abrégé: J Nippon Med Sch
Pays: Japan
ID NLM: 100935589
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
pubmed:
31
8
2020
medline:
18
1
2022
entrez:
1
9
2020
Statut:
ppublish
Résumé
We report a case of contact dermatitis caused by both efinaconazole, a topical triazole antifungal drug, and luliconazole, a topical imidazole antifungal drug. Positive patch test reactions were observed with efinaconazole and luliconazole. A patch test with lanoconazole also elicited a positive reaction. We hypothesized that structural similarity between luliconazole and lanoconazole led to cross-reaction, and that the dithiolane ring common to both drugs or the structure of the vinyl imidazole with a dithiolane ring could be the antigenic determinant. Since efinaconazole and luliconazole have no common structures, patients could be sensitized to both drugs separately. The antigenic determinant of efinaconazole is unknown. However, the chemical formula of ravuconazole, an oral triazole antifungal drug, is similar to that of efinaconazole. Clinicians should carefully consider potential cross-reactivity between these drugs.
Identifiants
pubmed: 32863343
doi: 10.1272/jnms.JNMS.2021_88-312
doi:
Substances chimiques
Antifungal Agents
0
Epitopes
0
Imidazoles
0
Triazoles
0
efinaconazole
J82SB7FXWB
luliconazole
RE91AN4S8G
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM